Forum Markets Reinstates Initial S-3 Registration for ATM Equity Offering Program

On April 8, 2026, Forum Markets, Incorporated (formerly 180 Life Sciences Corp.) entered into a Second Amended and Restated Sales Agreement with Clear Street LLC and TCBI Securities, Inc. (Texas Capital Securities). This agreement amends previous arrangements for the company's "at the market" (ATM) offering program. The primary purpose of this amendment is to transition the equity offering program back to the company's registration statement on Form S-3 (File No. 333-288194) and the initial prospectus supplement filed on August 13, 2025. Consequently, the company will cease all sales of common stock under its previous WKSI Registration Statement and WKSI Prospectus Supplement. Under the terms of the agreement, the company may issue and sell shares of common stock through the agents acting as sales agents or principals. The filing indicates there were no other material changes to the terms of the ATM program. The company remains responsible for ensuring that total sales do not exceed authorized limits or the dollar amount specified in the prospectus.